Middle East Pharma Declares SAR 0.80 Per Share Interim Dividend
AVALON PHARMA 4016.SA | 0.00 |
On August 10, 2026, Middle East Pharmaceutical Industries Company announced that its Board of Directors resolved on August 9, 2026, to distribute interim cash dividends to shareholders for the first half of 2026. The total distribution amounts to SAR 28,000,000, covering 35,000,000 eligible shares at SAR 0.80 per share, representing 8% of the share par value. The eligibility date is set for September 1, 2026, with dividends to be distributed on September 15, 2026. Non-resident foreign investors are advised that cash distributions are subject to a 5% withholding tax in accordance with applicable tax regulations.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=97442&anCat=1&cs=4016&locale=arImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.
